Nanoparticles Hold Promise to Improve Blood Cancer Treatment, University of Notre Dame Study

Published: Jun 18, 2012

Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.

Back to news